Inhibition of the proliferation of smooth muscle cells from human coronary bypass vessels by vasonatrin peptide

Physiological Research

Volumn 53, Issue 4, 2004, Pages 387-393

  Lu, Shun Yan ^a,b   Zhu, M Z ^a   Wang, D S ^a   Chen, S Y ^a   Zhang, W D ^a   Dong, H ^a   Yu, J ^a   Guo, H T ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Proliferation; Vascular smooth muscle cells; Vasonatrin peptide

Indexed keywords

8 BROMO CYCLIC GMP; CYCLIC GMP; GUANYLATE CYCLASE; NATRIURETIC FACTOR; NORADRENALIN; THYMIDINE; UNCLASSIFIED DRUG; VASONATRIN;

ARTICLE; ATHEROSCLEROSIS; CELL GROWTH; CELL PROLIFERATION; CORONARY ARTERY BYPASS GRAFT; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; MITOGENESIS; RADIOIMMUNOASSAY; RESTENOSIS; SAPHENOUS VEIN; VASCULAR SMOOTH MUSCLE;

ANALYSIS OF VARIANCE; ATRIAL NATRIURETIC FACTOR; CELL PROLIFERATION; CELLS, CULTURED; CORONARY ARTERY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; GROWTH INHIBITORS; HUMANS; MAMMARY ARTERIES; MUSCLE, SMOOTH, VASCULAR; SAPHENOUS VEIN;

EID: 4143119964     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. BONATTI J, DICHTL W, LERCHER A, PUSCHENDORF B: Natriuretic peptides stimulate cyclic guanosine monophosphate production in human saphenous vein and internal mammary artery. Eur J Cardiothorac Surg 17: 175-181, 2000.
2. CAMERON A, DAVIS KB, GREEN G, SCHAFF HV: Coronary bypass surgery with internal thoracic artery grafts -effects on survival over a 15-year period. N Engl J Med 334: 216-219, 1996.
3. CAMPBELL JH, CAMPBELL GR: Culture techniques and their applications to studies of vascular smooth muscle. Clin Sci 85: 501-513, 1993.
4. CANHAM PB, FINLAY HM, BOUGHNER DR: Contrasting structure of the saphenous vein and internal mammary artery used as coronary bypass vessels. Cardiovasc Res 34: 557-567, 1997.
5. DEL RIZZO DF, YURKOVA N, MOON MC, LITCHIE B, ZAHRADKA P: Platelet-derived growth factor-induced expression of c-fos in human vascular smooth muscle cells: implications for long-term graft patency. Ann Thorac Surg 74: 90-95, 2002.
6. 2+]i of cultured rat cardiac fibroblasts. Acta Physiol Sin 53: 286-290, 2001.
7. IKEDA T, ITOH H, KOMATSU Y, HANYU M, YOSHIMASA T, MATSUDA K, NAKAO K, BAN T: Natriuretic peptide receptors in human artery and vein and rabbit vein graft. Hypertension 27: 833-837, 1996.
8. LI S, SIMS S, JIAO Y, CHOW LH, PICKERING JG: Evidence from a novel human cell clone that adult vascular smooth muscle cells can convert reversibly between non-contractile and contractile phenotypes. Circ Res 85: 338-348, 1999.
9. LU SY, ZHU MZ, GUO HT, YU J, WEI QM: Inhibition of moderate hypoxia-induced protein synthesis by vasonatrin peptide in cultured neonatal rat cardiomyocytes. Acta Physiol Sin 54: 7-11, 2002.
10. MAJACK RA, GRIESHABER NA, COOK CL, WEISER MC, MCFALL RC, GRIESHABER SS, REIDY MA, REILLY CF: Smooth muscle cells isolated from the neointima after vascular injury exhibit altered responses to platelet derived growth factor and other stimuli. J Cell Physiol 167: 106-112, 1996.
11. MANCIA G, SERAVALLE G, GRASSI G: Sympathetic nervous factors, pressure variability and organ damage in arterial hypertension. Ann Ital Med Int 12: 217-222, 1997.
12. MORISHITA Y, SANO T, ANDO K, SAITOH Y, KASE H, YAMADA K, MATSUDA Y: Microbial polysaccharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase-containing receptor. Biochem Biophys Res Commun 176: 949-957, 1991.
13. PARENTI A, BROGELLI L, DONNINI S, ZICHE M, LEDDA F: ANG II potentiates mitogenic effect of norepinephrine in vascular muscle cells: role of FGF-2. Am J Physiol 280: H99-H107, 2001.
14. SCHWARTZ SM, DEBLOIS D, O'BRIEN ER: The intima. Soil for atherosclerosis and restenosis. Circ Res 77: 445-465, 1995.
15. SILBERBACH M, ROBERTS CT Jr: Natriuretic peptide signalling: molecular and cellular pathways to growth regulation. Cell Signal 13: 221-231, 2001.
16. SUGA S, NAKAO K, HOSODA K, MUKOYAMA M, OGAWA Y, SHIRAKAMI G, ARAI H, SAITO Y, KAMBAYASHI Y, INOUYE K, IMURA H: Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130: 229-239, 1992.
17. WEI CM, KIM CH, MILLER VM, BURNETT JC Jr: Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide. J Clin Invest 92: 2048-2052, 1993.
18. YU J, DONG MQ, LU SY, ZHU MZ: Use of vasonatrin peptide in the attenuation of norepinephrine-induced growth-promoting effects on cardiac myocytes. Chin J Cardiac Funct 11: 145-148, 1999.
19. YU SM, TSAI SY, GUH JH, KO FN, TENG CM, OU JT: Mechanism of catecholamine-induced proliferation of vascular smooth muscle cells. Circulation 94: 547-554, 1996.